Paul R. Flynn is VP at DEXCOM INC (DXCM). They have made 5 open-market trades across 1 company since 2021, most recently 2023-12-18.
CIK 0001850141
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DXCM | 48,949 | $4.3M |
Shares reported on the most recent Form 4, priced at the 2023-12-19 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DXCM | SELL | 2023-04-17 | 2023-04-18 | $120.00 | $334K | +2.2% | +0.2% | +15.7% |
| DXCM | SELL | 2023-03-13 | 2023-03-14 | $106.27 | $591K | +1.8% | +3.7% | +13.2% |
| DXCM | SELL | 2022-12-08 | 2022-12-08 | $123.50 | $1.1M | -7.0% | -9.5% | -7.3% |
| DXCM | SELL | 2021-09-09 | 2021-09-13 | $549.10 | $1.5M | +5.6% | +1.0% | +1.3% |
| DXCM | SELL | 2021-04-15 | 2021-04-16 | $400.00 | $303K | +7.4% | -18.0% | +11.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.